Abstract The mouse is a valuable model organism for studying bone biology and for unravelling pathological processes in skeletal disorders. In vivo methods like X-ray analysis, DXA measurements, pQCT and lCT are available to investigate the bone phenotype of mutant mice. However, the descriptive nature of such methods does not provide insights into the cellular and molecular bases of the observed bone alterations. Thus, first-line investigations might be complemented by cell culture-based methods to characterize the pathological processes at the cellular level independent from systemic influences. By combining wellestablished assays, we designed a comprehensive test system to investigate the cellular and molecular phenotype of primary calvarial osteoblasts in mutant mice compared to wild-type controls as a first-line phenotyping method. The compilation of 9 different quantifiable assays allows assessment of general properties of cell growth and investigation of bone-specific parameters at the functional, protein and RNA level in a kinetic fashion throughout a 3-week culture period, thus maximizing the chance to discover and explain new phenotypes in mutant mice. By analyzing mutant mouse lines for Col1a1 and Jag1 (DeltaNotch pathway) that both showed clear alterations in several bone-related parameters we could demonstrate the usefulness of our cell culture system to discriminate between primary (Col1a1) and secondary effects (Jag1) in osteoblasts.
Introduction
Although characterized by a hard and rigid nature, bone is a living and versatile organ possessing multiple functions [1] . Given the complex structure and diverse functions of the skeleton, a multitude of acquired or genetically caused diseases of the skeletal system are known. The mouse represents the premier genetic model organism to study human diseases and is a valuable tool for the investigation of bone biology [2] . Various mutant lines with skeletal defects have been developed using either spontaneous or Electronic supplementary material The online version of this article (doi:10.1007/s00774-012-0421-x) contains supplementary material, which is available to authorized users. targeted mutagenesis. To date, [3,400 genotypes with [13,300 annotations have been listed in the Mouse Genome Informatics (MGI) database for skeletal phenotypes (http://www.informatics.jax.org). In the Munich ENU (N-ethyl-N-nitrosourea) mutagenesis screen [3] , various mouse mutants with skeletal abnormalities like polydactyly, syndactyly, osteogenesis imperfect (OI), achondrodysplasia, osteoporosis or rheumatoid arthritis were identified ( [4, 5] and unpublished data).
Once a mouse mutant has been established as a model for a human bone disease, a comprehensive analysis of its phenotype is important to unravel the underlying physiological and molecular alterations. Phenotypic characterization of skeletal defects can be performed using X-ray analysis, DXA measurements, pQCT and lCT analysis, three-point bending tests or by determination of biochemical markers for bone formation and resorption [6] . Thus, a comprehensive picture of morphological, structural and clinical chemical alterations of the skeletal system in mutant mice can be obtained. However, such methods cannot assess if the alterations are caused by primary defects or by systemic influences on the bone cells, e.g., by hormonal/metabolic dysregulation (secondary effect). To study pathological processes at the cellular level independent from systemic influences, in vitro investigation of primary osteoblasts provides deeper insights into cellular differences of mutant and wild-type animals and can help to elucidate the molecular causes of bone alterations.
We took advantage of established in vitro assays to design a standardized, comprehensive and multifaceted cell culture system for the comparison of primary calvarial osteoblasts from mutant mice with wild-type controls. This allows us to maximize the potential for the discovery and characterization of new intrinsic pathomechanisms in osteoblasts. In stimulated cultures, the combination of nine different quantitative assays allows assessment of general properties of cell growth and investigation of bone-specific parameters at the functional, protein and RNA level. The assays are performed at multiple time points throughout a 3-week culture period to receive kinetic results for each parameter (a detailed standard operating procedure [SOP] for the osteoblast cell culture system is given in supplementary file S1). The system has been validated by the investigation of two mutant lines with clear alterations in bone-related parameters. Compared to wild-type, osteoblasts from Col1a1 Aga2 mice, a murine model for OI [5] , showed a different behavior in the culture system, which points to a primary defect in these cells as causative for the disease. In contrast, bone alterations of the second mutant line Jag1
Htu , carrying a missense mutation in the Jagged1 gene [7] , seem to be secondary, caused due to systemic effects, since mutant osteoblasts demonstrate a similar behavior compared to wild-type cells.
Materials and methods
A comprehensive description of the complete SOP including detailed material and method specification for cell isolation and all assays is provided in supplementary file S1.
Animal housing and handling
Mouse husbandry was conducted under specific pathogenfree conditions in compliance with the Federation of European Laboratory Animal Science Associations (FE-LASA) protocols. All mutants were produced and maintained on an inbred C3HeB/FeJ genetic background. Mice received standard rodent nutrition and water ad libitum. All animal experiments were performed under the approval of the responsible animal welfare authority.
Workflow
The time frame for a complete analysis of the osteoblast phenotype comprises 5 weeks after birth (Fig. 1) . To ensure identical cultivation, cells are prepared in parallel at 4-6 days of age. After 5 days in culture, the cells are stimulated (referred to as T0) and cultivated for 21 days under stimulating conditions. 9 different assays are performed at 5 defined time points to receive kinetic results for each parameter (referred to as measurement days T0/T3/ T9/T15/T21). To avoid differences in the analysis of a single assay, samples are collected and stored until the end of the cultivation period. Thereafter, each assay is evaluated by analyzing all samples in parallel (referred to as assay analysis). Thus, the simultaneous and uniform analysis of all samples from different measurement days Fig. 1 Workflow of the cell culture system ensured comparable and reliable results. A schedule for sample collection is provided in supplementary file S1.
Cell preparation and cultivation
Osteoblasts are isolated from 4-6-day-old mice using enzymatic digestion of the calvariae with collagenase [8, 9] . For the culture system, 12.4 9 10 6 cells are needed for each group (mut/wt). Briefly, calvariae of decapitated animals are dissected from the skull, released of superfluous tissues, washed in phosphate-buffered saline and treated with 4 mM ethylenediaminetetraacetic acid. After predigestion for 7 min with 0.1 % collagenase IV (Sigma-Aldrich, Germany), the calvariae are incubated twice with 0.1 % collagenase solution for 30 min to release the cells. After centrifugation the pellets are resuspended in culture medium A (see below). Finally, the cells of each group are pooled and plated in 24-well cell culture plates (5 9 10 4 cells/well), 6-well cell culture plates (2 9 10 5 cells/well) and T 12.5 cm 2 cell culture flasks (2.5 9 10 5 cells/flask) according to the scheme provided in supplementary file S1. The isolated cells are cultivated under standard conditions (37°C/90 % humidity/5 % CO 2 ). The medium is changed twice a week. Three different culture mediums are used. Culture medium A for preparation and the initial 5 day pre-culture period as well as for assay A1 (a-MEM supplemented with 10 % fetal calf serum [FCS]/2 mM glutamine/100 U/ml penicillin/100 lg/ml streptomycin). Medium B is used for stimulation of the cells (T0) and for maintenance of the stimulation conditions throughout the 3-week culture period (medium A with 10 mM b-glycerophosphate/50 lg/ml ascorbic acid). Medium C is needed for assay A2 (medium B with 5 % FCS).
Proliferation/metabolic activity/protein content/alkaline phosphatase (ALP) activity (A1) One 24-well Lumox TM plate is used for each measurement day. The sample wells (6 wt, 6 mut) are processed separately. The metabolic activity is assessed by adding Resazurin (CellQuanti-Blue TM Reagent; BIOTREND Chemikalien, Germany) to the culture medium [10] . Thereafter, cells are lysed, transferred into a tube and centrifuged to separate the nucleic fraction (pellet) and the cytosolic fraction (supernatant). Both fractions are stored at -20°C. The supernatant is used for determination of the ALP activity and the protein content. The latter is quantified using the BCA Protein Assay Kit (Thermo Scientific, Germany) [11] . The ALP activity of the cells is quantified by 4-nitrophenylphosphate [12] . The pellet is used to determine the proliferation rate of the cultivated cells by their DNA content with a fluorescent dye (Quant-iT TM dsDNA Assay Kit; Invitrogen, Germany). Thus, a growth curve for the culture is obtained and the DNA amount can further be used as a reference value to normalize the metabolic activity, protein content and ALP activity in the same sample.
Collagen secretion/collagen deposition (A2) One 6-well Primaria TM plate is used for each measurement day and the sample wells (3 wt, 3 mut) are processed separately. The culture supernatant is stored at -20°C and the cell layer is fixed with Bouins solution, covered with water and stored at room temperature (RT). Collagen is determined based on the precipitation of collagen by Sirius Red [13] . Secreted collagen (supernatant) is precipitated by the Sircol TM Dye reagent (tebu-bio, Germany) and quantified colorimetrically after dissolving the precipitate. Similarly, collagen that became incorporated into the extracellular matrix (ECM) layer is stained with Sirius Red FB3 (Sigma-Aldrich) and quantified colorimetrically after dissolving the dye from the matrix.
Matrix mineralization (A3)
One 6-well Primaria TM plate is used for each measurement day and the sample wells (3 wt, 3 mut) are processed separately. Cells are fixed in 4 % paraformaldehyde (PFA), air dried and stored at RT until analysis. Mineralization of the extracellular matrix is determined using Alizarin Red [14] .
Nodule quantification (A4) All 12.5 cm 2 cell culture flasks are used at each measurement day and are analyzed separately (4 wt, 4 mut). Flasks are placed under a stereomicroscope in a special custombuilt holding frame to ensure identical positions at each measurement day. Images are taken and the development of nodule-like structures is quantified using ImageJ software.
Gene expression (A5)
One 24-well Primaria TM plate is used for each measurement day. Cells of single wells of both biological groups are pooled (1 wt, 1 mut) and cell lysates are stored at -80°C. RNA is isolated, reverse transcribed into cDNA and applied for qPCR, which is performed in 384-well plates using the Taq-Man 7900HT device and SYBR Ò -Green (Applied Biosystems, Germany) for detection. All primers are listed in supplementary file S1. Determination of expression levels is performed by relative quantification according to the 2 -DDCt method [15] . For normalization, the C t values from two housekeeping genes are averaged to obtain a mean internal reference value in each sample. 
Statistical analysis
To obtain the number of cells required for the entire culture system, osteoblasts from multiple mice are pooled. Thus, biological replicates are not performed and the n-multiple wells/flasks of each group represent technical replicates, for which a standard error of the mean (SEM) is calculated. In assay A5, single wells of each group are pooled for RNA isolation and therefore, no technical replicates are performed and SEM is not calculated. Accordingly, the system provides only trends in terms of differences between mutant and wild-type osteoblasts, but the development and course of each investigated parameter during the cultivation period allows the detection of discrepancies between mutant and wild-type cells.
Important considerations
The quality of collagenase IV is important for the yield and vitality of the isolated cells [16] . Furthermore, the individual composition of FCS as the most important supplement for the culture media influences growth and differentiation of the cells critically [17] . Since strong variations in the quality of collagenase IV and composition of FCS can occur between different batches, it is advisable to test different batches for the culture system. We used the number of cells obtained per calvaria as an indicator for collagenase IV and the ability of osteoblasts to differentiate (determined by nodule quantification) as criterion for FCS.
Results

Growth and differentiation of the culture
The isolated calvarial cells appeared morphological polygonal/cuboidal (Fig. 2a) and were cultivated under proliferating conditions for 5 days to reach confluence.
Differentiation of the cells using b-glycerophosphate and ascorbic acid was morphologically distinguishable by the development of nodule-like structures (Fig. 2b, c) , which constantly increased in size throughout the cultivation period. Standard immunocytochemical analysis for Pdpn, a marker for osteocytes [18] , revealed exclusive staining of the three-dimensional nodules in stimulated cell cultures (Fig. 2d) . Initial experiments have shown that the ability and degree of differentiation and nodule formation depend on three important conditions. (1) Nodule formation occurred only in cells that were directly isolated from the calvaria (passage P0). Cultures that have been passaged were unable to develop nodules (data not shown). (2) The cell density at the time point of stimulation (T0) considerably influenced the degree of differentiation. The higher the cell density the more nodules were formed (Fig. 2e, f) . (3) The quality of the FCS was found to be crucial for differentiation of the culture, whereas number and size of nodules varied between different batches of FCS (data not shown).
Selection of suitable mouse mutants for validation of the culture system Two mutant lines with obvious bone phenotypes and known mutations have been chosen for the validation of the entire cell culture system. The Col1a1 Aga2 mutant line has recently been described as a new mouse model for OI with a dominant negative mutation in the Col1a1 gene causing structural alterations of the mutated type I collagen protein [5] . pQCT analysis revealed a strong decrease of total, trabecular and cortical bone mineral density (BMD) in the femoral metaphysis and diaphysis as well as a pronounced reduction of total and cortical/subcortical BMC. Furthermore, the total and cortical area was decreased and the trabecular area increased (Fig. 3a, b) . Taken together, Col1a1
Aga2 mice possess a clear bone phenotype and displayed hallmarks of OI symptoms with multiple fractures, scoliosis and an overall decrease in bone mass and density.
The second mutant line, Jag1 Htu was also identified in the Munich ENU mutagenesis screen based on an abnormal head-shaking phenotype [7] . Bone densitometry disclosed significantly increased specific BMD (sBMD = BMD related to the body weight) values. Furthermore, pQCT analysis indicated an increase of total and trabecular BMD, total and cortical/subcortical bone mineral content (BMC) as well as total and cortical area of bone metaphysis and diaphysis in the mutants. The trabecular BMC and trabecular area in the metaphysis showed reduced values (Fig. 3c,  d ). Taken together, Jag1
Htu animals depicted a clear bone phenotype with an increase of cortical bone and a higher trabecular bone mineral density compared to controls. Given the distinct alterations in their bone parameters, both mutant lines were considered to be suitable candidates for the validation of our primary calvarial osteoblast cell culture system. To determine differences between mutant and control groups we calculated the ratio of the values at each time point for every assay (except the expression analysis). We considered a difference of 20 % between mutant and control as a distinct difference (see Supplementary Fig. 1 ).
Proliferation/metabolic activity/protein content/ALP activity (A1)
In wild-type cells, proliferation was highest during the initial phase of development and reached a plateau 15 days after stimulation (Fig. 4a) . The metabolic activity decreased in the first 10 days and remained at low levels towards the end of the culture period while protein content strongly increased during the first 3-4 days and remained constant afterwards (Fig. 4b, c) . The ALP activity increased throughout the cultivation period (Fig. 4d) . Col1a1 Aga2 osteoblasts possessed a similar behavior for Fig. 4 In vitro analysis of primary calvarial osteoblasts from Col1a1 Aga2 and Jag1 Htu mice. The analysis was performed according to the developed SOP and the results of both studies are displayed with diagrams for each assay. The error bars represent the SEM values calculated from the technical replicates (number of wells per assay, see SOP). The y-axis indicates the assay and the x-axis the day of analysis (for h, deviating from the SOP, measurements were performed at different days for Col1a1
Aga2 and Jag1 Htu due to technical reasons). While in calvarial cultures of Col1a1 Aga2 mice almost all parameters differ considerably compared to wild-type control cells, no obvious differences can be observed for calvarial cultures of Jag1 Htu mice metabolic activity and protein content (Fig. 4b, c) . However, Col1a1 Aga2 cells depicted a reduced initial proliferation period followed by a short growth arrest and a second increase towards the end of the culture period (Fig. 4a) , and ALP activity was reduced at all time points (Fig. 4d) . In contrast, all 4 parameters were unchanged in the Jag1 Htu culture (Fig. 4a-d) .
Collagen secretion/collagen deposition (A2)
In wild-type cultures, collagen secretion continuously decreased until day 15 and remained constant thereafter, while matrix collagen deposition increased throughout the 3-week culture period. Col1a1
Aga2 cultures showed clear differences with lower values for both parameters, while Jag1
Htu osteoblasts depicted similar values for secreted and deposited collagen compared to wild-type controls at each time point analyzed (Fig. 4e, f) .
Matrix mineralization (A3) and nodule quantification (A4)
The mineralization of the ECM increased in wild-type cultures continuously until day 15 after stimulation and plateaued afterwards. Nodules first appeared after 7 days and increased in size towards the end of the culture period.
Col1a1
Aga2 cells showed striking differences in both assays with higher values for ECM mineralization and a significantly reduced nodule formation rate (Fig. 4g, h ). Compared to wild-type control Jag1
Htu osteoblasts possessed an identical behavior for both parameters (Fig. 4g, h ).
Gene expression (A5)
The results of the expression analyses for both mutant lines are summarized in Fig. 5a . Additionally, the expression of Col1a1 and Alpl is exemplarily graphed below (Fig. 5b, c) .
Aga2 cultures, 9 of 13 marker genes varied with an expression difference [50 % in at least one time point or expression differences of 25-50 % in at least 3 time points compared to wild-type, while in Jag1 Htu cultures only 3 marker genes displayed expression differences.
Taken together, calvarial cells from Col1a1 Aga2 mice showed significant differences in almost all parameters analyzed whereas Jag1
Htu osteoblasts were nearly indistinguishable from wild-type controls.
Discussion
The calvaria as flat bone is formed by intramembranous ossification whereas most of the appendicular and axial skeleton is formed by endochondral ossification [19] . In a recent study, enzymatic isolation of fetal calvarial cells was shown to be most suitable concerning proliferative capacity and osteogenic potential [20] . Furthermore, the authors also found differences in ALP activity and mineralization between in vitro cell cultures from calvariae and long bones, a fact that has to be taken into account when results are correlated to bone alterations observed in long bones (endochondral). In addition, neonatal cell cultures behave differently and contain more immature, rapidly growing cells than cultures from adult bone [9] . Therefore, the age of the animals has also to be considered for the interpretation of results from a mutant line with a late onset of the bone disease.
In our cell culture system, isolated calvarial cells possessed the typical cuboidal morphology of osteoblasts [9] and the degree of their differentiation strongly correlated with the initial cell density and the FCS used [17, 21] .
Nine different assays have been designed to ensure a comprehensive investigation of the osteoblast phenotype. ALP, mineralization and nodule formation are widely used indicators for the osteogenic potential of osteoblast cell cultures [17, 20] . Nodules, which only appeared in stimulated cultures, contained osteocyte-like cells [22] confirmed by immunofluorescence staining of Pdpn [18] . Consequently, the rate of nodule formation is an indicator for the differentiation to a more mature (osteocyte-like) phenotype. Because collagen is the most abundantly expressed protein in the ECM and isolated osteoblasts synthesize primarily type I collagen (*95 %) [21] , we implemented the measurement of collagen secretion and deposition to further assess the osteogenic capacities of mutant and wild-type osteoblasts. Finally, we analyzed 13 bone-relevant marker genes covering all developmental stages of in vitro osteoblast culture by qRT-PCR [23] . All assays have been designed to allow the quantification of parameters in a kinetic way throughout a 3-week culture period, to identify distinct phenotypes.
Validation of the culture system
To validate our cell culture system and to examine the practicability of its SOP, we analyzed two mutant lines with striking bone phenotypes.
Wild-type osteoblasts
The course of cell growth reflects three distinct proliferation periods (exponential growth, postconfluent proliferation and compensatory proliferation) [24] . Given that replication and cell growth are energetically expensive processes, the metabolic activity of the culture is highest at the beginning and decreases during matrix maturation and mineralization when the initial proliferation is restricted to differentiation [24, 25] . In contrast, protein synthesis is low during the initial proliferation phase but increases when the ECM is produced and remains high for matrix maintenance and reorganization.
The osteogenic potential of the culture markedly increases at the end of the growth period, according to the reciprocally and functionally coupled relationship between the decline in proliferative activity and the subsequent induction of genes (e.g., Spp1, Bglap) associated with matrix maturation and mineralization [23, 25] . Although Col1a1 mRNA peaked during the proliferative phase, the overall synthesis and incorporation of collagen into the ECM increased during the entire culture period [25] . This time lag between mRNA expression and collagen incorporation is consistent with a previous report demonstrating uncoupling of type I collagen synthesis and collagen accumulation in developing osteoblasts [26] . Taken together, the cells recapitulate the in vitro developmental sequence of proliferation, differentiation and ECM maturation/mineralization [23] . Therefore, the cell culture system is highly suitable to study bone cell characteristics of different mutant mouse lines.
Aga2 osteoblasts
In comparison to wild-type, calvarial cells from Col1a1 Aga2 mice displayed different characteristics of osteoblast development. No obvious differences where found in the metabolic activity and overall protein synthesis, which is consistent with a report demonstrating that the amount of total protein synthesized by human OI bone cells in culture was unchanged compared to controls although collagen itself was significantly reduced [27] . Similar to our results for Col1a1 Aga2 osteoblasts, a decrease of the maximal in vitro growth rate was described for osteoblasts from OI patients [27, 28] . Astonishingly, matrix mineralization of Col1a1 Aga2 cells as measured by calcium incorporation was higher compared to controls. Recent findings suggest coherence between collagen structure and mineralization pattern [29] . Thus, it is conceivable that the incorporation of mutated Col1a1 chains into the Col1a1
Aga2 matrix might involve alterations of nucleation sites leading to higher calcium incorporations. Indeed, our findings are in correlation to studies that demonstrated higher mineralization in human OI patients [30] .
The alterations on the protein and functional level in Col1a1
Aga2 could be confirmed by expression analysis, wherein almost all bone marker genes were altered indicating diminished differentiation and matrix maturation. For example, the downregulation of the ECM protein genes Bglap, Spp1 and Ibsp at the end of the cultivation period is in accordance with a disordered osteoblast differentiation [31] [32] [33] . The results obtained from the Col1a1 Aga2 culture could be explained by interactions between proliferation, ECM maturation and osteoblast differentiation. The expression of the mutated type I collagen in Col1a1
Aga2 osteoblasts yields in the activation of endoplasmic reticultum stress and induction of apoptosis as well as reduced type I collagen secretion accompanied by structural and functional ECM impairments that also explain the discrepancy between collagen expression and secretion/deposition [5] . Since a proper ECM is necessary for cellular differentiation and function [19] , and a critical role of type I collagen in mediating the expression of a mature osteoblast phenotype has already been proposed [34] , the irregular ECM in Col1a1
Aga2 cultures prevent appropriate osteoblast development. Furthermore, proliferation needs to be decreased for differentiation to occur [23, 25] . Therefore, the increased proliferative activity of Col1a1
Aga2 cells towards the end of the culture period might impede or delay the transition between proliferation and differentiation. The reduced proliferation at the beginning and the increased proliferation towards the end of the culture period might be explained by the previously reported link between type I collagen synthesis and cellular proliferation, which claims that destabilized collagen triple helix formation and altered collagen secretion decreases the growth rate [28] . The increased apoptotic rate in Col1a1
Aga2 osteoblasts [5] might further account for the decreased proliferation, whereby the second rise in proliferative activity might be seen as a compensatory mechanism.
Given that the osteoblasts are cultivated under identical conditions independent from systemic influences, the differences between mutant and wild-type cells refer to a primary defect in Col1a1
Aga2 osteoblasts as the cause for the bone phenotype, in which inappropriate collagen synthesis and secretion result in a diminished or at least delayed extracellular matrix maturation and osteoblast differentiation.
Jag1
Htu osteoblasts Jag1 Htu mice possess a mutation in the Jag1 gene [7] . Mutations in human Jag1 are responsible for Alagille syndrome (AGS), a pleiotropic developmental disorder characterized by cholestasis due to bile duct paucity, poor lung function, cardiac abnormalities and skeletal alterations such as butterfly vertebrae [35] . In contrast to AGS patients, who suffer from osteopenia due to hepatic osteodystrophy [36] , Jag1 Htu mice had more robust bones. Given that the mutation in Jag1
Htu resides in the second EGF-like repeat of Jag1, which is important for Notch binding [7] , it is conceivable that a failing of Notch activation accounts for the augmented bone phenotype. Previous studies have shown that Notch normally inhibit osteoblastogenesis and impairs osteoblast differentiation [37] and transgenic mice lacking Notch signaling in skeletogenic mesenchyme exhibit increased bone parameters [38] . However, the effect is reversed in older mice and long-term inhibition of Notch results in osteoporotic mice. This phenotype has never been observed in aged Jag1 Htu mice in vivo. Moreover, except for an upregulation of Bglap and Ibsp in the gene expression analysis, the in vitro cultivation of osteoblasts under identical conditions without systemic influences revealed an identical behavior and phenotype of Jag1
Htu osteoblasts compared to wild-type controls. Taken together, this argues against a primary defect with failing Jag1-Notch interaction in osteoblasts as a cause of the bone phenotype in Jag1
Htu . As Jag1
Htu mice display an increased angular velocity and forward locomotor activity, which might be related to the vestibular defect in these mutants [7] , a systemic effect might be responsible for the bone phenotype in these mutants. Previous studies have shown that enhanced locomotor activity in laboratory mice markedly increased BMC, bone mass and density as well as cortical area of long bones and concomitantly enhances bone mechanical properties [39, 40] .
Alternatively, a failing interaction between osteoblasts and hematopoietic stem cells (HSC) could also account for the osteopetrotic phenotype of Jag1
Htu . Studies addressing interactions of those cell types demonstrated recently that Jag1 expression in osteoblasts could induce Notch signaling in HSC and affect osteoclastogenesis [41] . Thus, an inadequate induction of Notch in HSC by the mutated Jagged1 could lead to an improper osteoclastogenesis, yielding in the osteopetrotic phenotype of Jag1
Htu . This possibility cannot be ruled out by our cell culture system.
Concluding remarks
This cell-cell culture system was designed for a first-line phenotyping of osteoblasts on the cellular level. If distinct differences are apparent, it will be necessary to examine single animal samples to receive biological replicates in the different assays. Furthermore, methods might be extended (e.g., whole-genome transcriptomics) or added (e.g., protein analysis of RANKL and OPG) to further elucidate molecular mechanisms.
The skeletal system is maintained by a precisely regulated interaction between bone formation (osteoblasts) and bone resorption (osteoclasts) in the process of remodeling (homeostasis). Thus, the investigation of osteoblasts allows for estimating the formation process only but alterations in bone resorption and osteoblast-osteoclast interactions cannot be disclosed. Therefore, in vitro analysis of osteoclasts can be implemented to broaden the phenotyping options of the cell culture system. Tartrate-resistant acid phosphatase staining and pit formation assays could be performed to evaluate osteoclast development and function [42] . To further extend the cellular analysis and unravel possible dysregulations in cell-cell communication, coculture systems can be applied combining, for example, osteoblasts with mesenchymal stem cells, osteoclasts or chondrocytes.
